BRIEF published on 06/04/2026 at 06:10, 2 months 11 days ago Health Advocates Urge FIFA to Sever Coca-Cola Ties by 2030 Coca-Cola World Cup 2026 FIFA Health Advocacy Sugar Consumption
BRIEF published on 06/04/2026 at 06:10, 2 months 11 days ago Des défenseurs de la santé exhortent la FIFA à rompre ses liens avec Coca-Cola d'ici 2030 Défense Des Droits Des Patients Coupe Du Monde 2026 Coca-Cola FIFA Consommation De Sucre
BRIEF published on 06/04/2026 at 05:00, 2 months 11 days ago First Graphene Expands in USA with MITO Acquisition First Graphene MITO Acquisition Graphene Technologies US Defence Market Aerospace Opportunities
BRIEF published on 06/04/2026 at 05:00, 2 months 11 days ago First Graphene se développe aux États-Unis grâce à l'acquisition de MITO. Premier Graphène Acquisition MITO Technologies Du Graphène Marché De La Défense Américain Opportunités Dans Le Secteur Aérospatial
BRIEF published on 06/04/2026 at 02:05, 2 months 11 days ago Quantinuum Sets Price for Upsized IPO Nasdaq Listing Class A Shares Underwriting SEC Registration Quantinuum IPO
BRIEF published on 06/04/2026 at 02:05, 2 months 11 days ago Quantinuum fixe le prix de son introduction en bourse majorée Souscription Actions De Catégorie A Cotation Au Nasdaq Enregistrement Auprès De La SEC Introduction En Bourse De Quantum
BRIEF published on 06/04/2026 at 00:15, 2 months 11 days ago Bitmine Immersion Technologies Proposes Series A Preferred Stock Offering Preferred Stock Digital Assets NYSE Listing BitMine Immersion Dividend Offering
BRIEF published on 06/04/2026 at 00:15, 2 months 11 days ago Bitmine Immersion Technologies propose une offre d'actions privilégiées de série A Actifs Numériques Actions Privilégiées Cotation Au NYSE Immersion Dans Bitmine Offre De Dividendes
BRIEF published on 06/04/2026 at 00:10, 2 months 11 days ago Semaglutide Improves Quality of Life in Diabetes and Kidney Disease Kidney Disease Quality Of Life Type 2 Diabetes Semaglutide FLOW Trial
BRIEF published on 06/04/2026 at 00:10, 2 months 11 days ago Le sémaglutide améliore la qualité de vie des personnes atteintes de diabète et de maladies rénales. Diabète De Type 2 Qualité De Vie Semaglutide Maladie Du Rein Essai FLOW
Published on 08/15/2026 at 00:50, 6 hours 33 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 7 hours 8 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 7 hours 38 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 7 hours 58 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 8 hours 23 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 13 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 15 hours 18 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 15 hours 54 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 13 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 13 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 13 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 13 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
